| Net Cash Provided by (Used in) Operating Activities |
$83,452,000 |
USD |
-158% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$84,766,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
88,086,000 |
shares |
7.1% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,183,000 |
USD |
-98% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$80,813,000 |
USD |
-36% |
Q4 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$25,724,000 |
USD |
-6.8% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$6,400,000 |
USD |
-29% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$6,500,000 |
USD |
-25% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$19,000 |
USD |
36% |
Q4 2025 |
Q1 2026 |
| Additional Paid in Capital |
$2,350,075,000 |
USD |
3.8% |
Q4 2025 |
Q1 2026 |
| Interest Expense |
$111,942,000 |
USD |
-12% |
Q4 2025 |
Q1 2026 |